Marthe Fourcade

UK health officials have reported a person with a flu strain typically found in pigs, marking the first time this variant has been detected in a human in the country.

Argenx SE shares plunged after the Dutch biotech said preliminary results from a study suggest its only medicine failed in a trial for a rare bleeding disorder.

Carmot Therapeutics Inc. was valued at $1.25 billion in May. Half a year later, the company is selling to Swiss drugmaker Roche Holding AG for more than double that amount, fueled by the frenzied demand for obesity medicines.

Carmot Therapeutics Inc. was valued at $1.25 billion in May. Half a year later, the company is selling to Swiss drugmaker Roche Holding AG for more than double that amount, fueled by the frenzied demand for obesity medicines.

Roche Holding AG said an experimental medicine helped women with a particular breast cancer mutation live longer without the disease progressing.

Hello, it’s Marthe in Paris. Having just edited my colleagues Naomi and Madison’s article on Wegovy for alcoholism, I’m wondering if the new obesity medicines will turn out to be a panacea for a horde of ailments. But first...

Novo Nordisk A/S’s largest shareholder plans to invest as much as $7 billion a year by 2030, buoyed by the success of the Danish drugmaker’s blockbusters for obesity and diabetes, the Financial Times reported.

The safety of intermittent fasting, a popular strategy to lose weight by limiting food intake to certain times, was called into question by a surprise finding from research presented at a medical meeting.

Roche Holding AG said an experimental breast-cancer treatment will get an expedited review from US regulators after showing it helped patients live longer without the disease progressing.

Ipsen SA and partner Genfit SA won US regulators’ clearance for the first new treatment option in eight years for patients with a rare liver disease.